- Home
- ITP vs SNGX Comparison
ITP vs SNGX Comparison
Compare ITP & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITP
- SNGX
- Stock Information
- Founded
- ITP 1996
- SNGX 1987
- Country
- ITP China
- SNGX United States
- Employees
- ITP N/A
- SNGX N/A
- Industry
- ITP Paper
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- ITP Basic Materials
- SNGX Health Care
- Exchange
- ITP Nasdaq
- SNGX Nasdaq
- Market Cap
- ITP 3.6M
- SNGX 4.3M
- IPO Year
- ITP N/A
- SNGX 1987
- Fundamental
- Price
- ITP $0.20
- SNGX $2.74
- Analyst Decision
- ITP
- SNGX Strong Buy
- Analyst Count
- ITP 0
- SNGX 1
- Target Price
- ITP N/A
- SNGX $6.00
- AVG Volume (30 Days)
- ITP 4.9M
- SNGX 19.3M
- Earning Date
- ITP 08-11-2025
- SNGX 08-12-2025
- Dividend Yield
- ITP N/A
- SNGX N/A
- EPS Growth
- ITP N/A
- SNGX N/A
- EPS
- ITP N/A
- SNGX N/A
- Revenue
- ITP $79,871,368.00
- SNGX $2,342.00
- Revenue This Year
- ITP N/A
- SNGX N/A
- Revenue Next Year
- ITP N/A
- SNGX N/A
- P/E Ratio
- ITP N/A
- SNGX N/A
- Revenue Growth
- ITP 8.49
- SNGX N/A
- 52 Week Low
- ITP $0.15
- SNGX $1.09
- 52 Week High
- ITP $1.07
- SNGX $5.40
- Technical
- Relative Strength Index (RSI)
- ITP 45.25
- SNGX 77.06
- Support Level
- ITP $0.18
- SNGX $1.18
- Resistance Level
- ITP $0.23
- SNGX $5.38
- Average True Range (ATR)
- ITP 0.01
- SNGX 0.38
- MACD
- ITP -0.00
- SNGX 0.16
- Stochastic Oscillator
- ITP 12.50
- SNGX 37.14
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).